This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
The Texas Tech University Health Sciences Center (TTUHSC) just recently purchased one of BrainsWay’s TMS devices within the last few months. The TTUHSC was able to purchase this through a major donation from the Psychiatry department. Now, the device is able to be used for the Laura W. Bush Institute for women’s health in order to support health initiatives.